Y Combinator Names Surbhi Sarna Its First-Ever Partner For Healthcare And Biotech

Subhi Sarna sold nVision Medical for $275 million in 2018. Now she's been named Y Combinator's first-ever group partner focused on healthcare and biotech as part of a pandemic-fueled deeper focus from the startup accelerator.

Source: Forbes.com Healthcare News - October 26, 2021 Category: Pharmaceuticals Authors: Alex Konrad, Forbes Staff Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Science /science Leadership /leadership ForbesWomen /forbeswomen Entrepreneurs /entrepreneurs Editors' Pick editors-pick technology Source Type: news